首页> 美国卫生研究院文献>Hepatitis Monthly >Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

【2h】

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

机译：利巴韦林在聚乙二醇化干扰素Alfa-2a联合治疗丙型肝炎患者期间损害唾液腺功能

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundXerostomia is a common adverse event of unknown etiology observed during pegylated interferon (PegIFN)/Ribavirin (Rbv) treatment.

机译：背景口干症是在聚乙二醇化干扰素（PegIFN）/利巴韦林（Rbv）治疗期间观察到的病因不明的常见不良事件。

著录项

期刊名称 Hepatitis Monthly
作者
Alessio Aghemo; Maria Grazia Rumi; Sara Monico; Matteo Banderali; Antonio Russo; Francesco Ottaviani; Mauro Vigano; Roberta D’Ambrosio; Massimo Colombo;
展开▼
作者单位

展开▼
年(卷),期 2011(11),11
年度 2011
页码 918–924
总页数 7
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Ribavirin Peginterferon Alfa-2a Salivary Glands Hepatitis C Hepatitis B;

机译：利巴韦林;聚乙二醇干扰素Alfa-2a;唾液腺;丙型肝炎;乙型肝炎;

相似文献

外文文献
中文文献
专利

1. RIBAVIRIN IMPAIRS SALIVARY GLAND FUNCTION IN HEPATITIS C PATIENTS DURING COMBINATION TREATMENT WITH PEGYLATED INTERFERON ALFA-2A [J] . AGHEMO ALESSIO, GRAZIA RUMI MARIA, MONICO SARA, Hepatitis Monthly . 2011,第11期

机译：利巴韦林在聚乙二醇化干扰素ALFA-2A联合治疗期间损害丙型肝炎患者唾液腺功能
2. Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients [J] . Alessio Aghemo, Maria Grazia Rumi, Sara Monico, Hepatitis Monthly . 2011,第11期

机译：利巴韦林与聚乙二醇化干扰素Alfa-2a联合治疗丙型肝炎患者期间唾液腺功能受损
3. Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b [J] . Tomasz H. Mach, Andrzej Cie?la, Wioleta Warunek, Polish Archives of Internal Medicine . 2011,第12期

机译：聚乙二醇干扰素α-2a或α-2b联合利巴韦林治疗丙型肝炎病毒基因型1b引起的慢性肝炎的疗效
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment [O] . Yang Hyun Baek, Sung Wook Lee, Hyun Seung Yoo, 2007

机译：胸腺素α-1与聚乙二醇干扰素和利巴韦林合用在先前未接受聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者中
7. Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients [O] . Aghemo, Alessio, Rumi, Maria Grazia, Monico, Sara, 2011

机译：利巴韦林与聚乙二醇化干扰素Alfa-2a联合治疗丙型肝炎患者期间唾液腺功能受损

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅